The American Hospital Association is asking the Federal Trade Commission and the Department of Justice to get involved in the ...

The hospital lobby wants the Trump administration to investigate Johnson & Johnson, Eli Lilly, Sanofi, Novartis and Bristol ...

The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several ...

The American Hospital Association is calling on federal regulators to launch an antitrust investigation into its claims of drug manufacturers’ actions regarding 340B rebate models. In a letter sent to ...

The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.

INDIANAPOLIS (Indiana Capital Chronicle) — A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many ...

The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992 ...

The 340B program is well-intentioned, but its design—funding institutions over patients—has led to widespread abuse and system manipulation.

The somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year.